ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
1.570
-0.020 (-1.26%)
Jun 11, 2026, 3:58 PM CET
STO:EXPRS2 Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 21.84 | 47.56 | 81.54 | 57.6 | 110.97 | 37.11 |
Short-Term Investments | - | - | - | - | - | 101.77 |
Cash & Short-Term Investments | 21.84 | 47.56 | 81.54 | 57.6 | 110.97 | 138.88 |
Cash Growth | -62.34% | -41.68% | 41.57% | -48.10% | -20.09% | 30.00% |
Accounts Receivable | 1.03 | 1.19 | 1.19 | 2.35 | 0.83 | 1.62 |
Other Receivables | 9.84 | 7.21 | 11.48 | 8.2 | 9.97 | 5.48 |
Receivables | 10.87 | 8.4 | 12.67 | 10.56 | 10.79 | 7.11 |
Prepaid Expenses | 10.31 | 0.76 | 1.15 | 0.52 | 10.18 | 0.48 |
Other Current Assets | - | 0.82 | - | - | - | - |
Total Current Assets | 43.02 | 57.53 | 95.36 | 68.67 | 131.94 | 146.46 |
Property, Plant & Equipment | 0.27 | 0.47 | 1.54 | 1.77 | 0.91 | 1.21 |
Long-Term Investments | 4.39 | 4.34 | 4.62 | 4.46 | 0.03 | 0.02 |
Other Intangible Assets | 1.41 | 1.5 | 2.08 | 2.47 | 2.95 | 3.14 |
Other Long-Term Assets | 1.32 | 1.27 | 1.32 | 1.32 | 1.53 | 1.12 |
Total Assets | 50.4 | 65.11 | 104.91 | 78.69 | 137.36 | 151.96 |
Accounts Payable | 1.64 | 4.04 | 8.47 | 1.84 | 12.15 | 1.69 |
Short-Term Debt | 0.52 | 0.5 | 0.36 | 0.28 | 1.76 | 1.92 |
Other Current Liabilities | 20.81 | 23.71 | 29.42 | 9.27 | 17.51 | 3.86 |
Total Current Liabilities | 22.96 | 28.26 | 38.25 | 11.38 | 31.43 | 7.46 |
Long-Term Leases | 0.73 | 0.85 | 1.44 | 1.44 | 0.09 | 0.19 |
Other Long-Term Liabilities | 0.29 | 0.31 | 0.43 | 0.51 | 2.52 | 3.96 |
Total Liabilities | 23.99 | 29.42 | 40.11 | 13.33 | 34.04 | 11.61 |
Common Stock | 15.69 | 15.69 | 11.82 | 5.71 | 4.18 | 3.46 |
Additional Paid-In Capital | 172.72 | 207.08 | 269.62 | 529.75 | 338.65 | 266.24 |
Comprehensive Income & Other | -161.99 | -187.08 | -216.63 | -470.1 | -239.5 | -129.36 |
Shareholders' Equity | 26.42 | 35.69 | 64.8 | 65.36 | 103.33 | 140.35 |
Total Liabilities & Equity | 50.4 | 65.11 | 104.91 | 78.69 | 137.36 | 151.96 |
Total Debt | 1.25 | 1.35 | 1.8 | 1.71 | 1.85 | 2.11 |
Net Cash (Debt) | 20.6 | 46.2 | 79.74 | 55.89 | 109.12 | 136.77 |
Net Cash Growth | -63.40% | -42.06% | 42.69% | -48.79% | -20.21% | 30.94% |
Net Cash Per Share | 5.83 | 13.09 | 47.16 | 48.44 | 124.37 | 187.09 |
Filing Date Shares Outstanding | 3.53 | 3.53 | 2.66 | 1.29 | 0.94 | 0.78 |
Total Common Shares Outstanding | 3.53 | 3.53 | 2.66 | 1.29 | 0.94 | 0.78 |
Working Capital | 20.05 | 29.27 | 57.11 | 57.29 | 100.52 | 139 |
Book Value Per Share | 7.48 | 10.11 | 24.38 | 50.86 | 109.90 | 180.20 |
Tangible Book Value | 25.01 | 34.18 | 62.72 | 62.89 | 100.37 | 137.21 |
Tangible Book Value Per Share | 7.09 | 9.68 | 23.59 | 48.94 | 106.76 | 176.17 |
Machinery | - | 8.76 | 9.31 | 8.15 | 6.24 | 5.36 |